期刊文献+

病理性瘢痕血管生成的研究进展 被引量:1

原文传递
导出
摘要 近年来,在肿瘤相关的研究中,抑制血管生成治疗肿瘤取得了良好的效果…。临床上病理性瘢痕的发生具有类似肿瘤的增殖方式,尤其是瘢痕疙瘩。借鉴肿瘤发病机制及防治研究中血管生成的有关理论,国内外学者们开始关注瘢痕形成中的血管因素。瘢痕组织内血管生成过多、血供丰富支撑了瘢痕的过度增生,还是瘢痕组织中供血不足、组织缺氧诱发了病理性瘢痕的发展,这两种观点对立存在。
出处 《中华整形外科杂志》 CAS CSCD 北大核心 2008年第3期246-249,共4页 Chinese Journal of Plastic Surgery
  • 相关文献

参考文献36

  • 1卞修武.对肿瘤血管生成研究之肿瘤微血管构筑表型异质性的思考[J].中华病理学杂志,2006,35(3):129-131. 被引量:24
  • 2Kischer CW, Shetlar MR. Microvasculature in hypertrophic scars and the effects of pressure.J Trauma, 1979, 19(10) :757-764. 被引量:1
  • 3Kischer CW, Thies AC, Chvapil M. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids, Hum Pathol, 1982, 13(9):819-824. 被引量:1
  • 4Beer TW, Baldwin HC, Goddard JR, et al. Angiogenesis in pathological and surgical scars. Hum Pathol, 1998, 29( 11 ) : 1273- 1278. 被引量:1
  • 5Tokuda Y, Crane S, Yamaguchi Y, et al. The levels and kinetics of oxygen tension detectable at the surface of human dermal fibroblast cultures. J Cell Physiol, 2000, 182(3) :414-420. 被引量:1
  • 6Niessen FB, Spauwen PH, Schalkwijk J, et al. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg, 1999, 104(5) : 1435-1458. 被引量:1
  • 7商庆新,张涤生,关文祥,周慧君.丹参和川芎嗪对瘢痕成纤维细胞生长的体外抑制实验[J].中国修复重建外科杂志,1998,12(6):321-324. 被引量:60
  • 8Haroon ZA, Raleigh JA, Greenberg CS, et al. Early wound healing exhibits eytokine surge without evidence of hypoxia. Ann Surg, 2000, 231(1): 137-147. 被引量:1
  • 9Timar Banu O, Beauregard H, Tousignant J, et al. Development of noninvasive and quantitative methodologies for the assessment of chronic ulcers and scars in humans. Wound Repair Regen, 2001, 9 (2) :123-132. 被引量:1
  • 10Tanaka A, Hatoko M, Tada H, et al. Expression of p53 family in scars. J Dermatol Sci, 2004, 34(1):17-24. 被引量:1

二级参考文献81

共引文献188

同被引文献10

  • 1卞修武.对肿瘤血管生成研究之肿瘤微血管构筑表型异质性的思考[J].中华病理学杂志,2006,35(3):129-131. 被引量:24
  • 2Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis a new significant and independent prognostic factor in early-stage breast carcinoma. J Natl Cancer Inst, 1992, 84(24): 1875-1887. 被引量:1
  • 3Kato J, Kuwabara Y, Mitani M, et al. Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer, 2001, 95(2):92-95. 被引量:1
  • 4Gougos A, Letarte M. Identification of a human endothelial cell antigen with monoelonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol, 1988, 141 (6): 1926- 1933. 被引量:1
  • 5Ambrosini G, Adida C, Ahieri DC. A novel anti apoptosis gene, survivin, expressd in cancer and lymphoma. Nat Med, 1997,3(8) :917-921. 被引量:1
  • 6Shin S, Sung BJ, Cho YS, et al. An anti-apoptoric protein human survivin is a direct inhibitor of caspase-3 and-7. Biochemistry, 2001,40(4) :1117-1123. 被引量:1
  • 7O'Connor DS, Schechner JS, Adida C, et al. Control of apotosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol, 2000,156(2):393-398. 被引量:1
  • 8Mesri M, Morales-Ruiz M, Ackermann EJ, et al. Suppression of vascular endothelial growth factor-mediate endothelial cell protection by survivin targeting. Am J Pathol, 2001, 158 (5) : 1757- 1765. 被引量:1
  • 9李小静,孟刚,宁金龙,张林.免疫组化法对不同类型瘢痕微血管的定量研究[J].实用美容整形外科杂志,2000,11(4):207-209. 被引量:6
  • 10李小静,孟刚.瘢痕微血管构筑的研究进展[J].中国临床康复,2002,6(4):480-481. 被引量:9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部